Cosmo Pharmaceuticals S.p.A Share Price Swiss Exchange
Equities
IT0004167463
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
03/06 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
26/04 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
Sales 2023 | 96.72M 104M 93.6M 8.73B | Sales 2024 * | 264M 285M 255M 23.78B | Capitalization | 1.24B 1.34B 1.2B 112B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.08M 968K 90.22M | Net income 2024 * | 124M 134M 120M 11.19B | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.31M 46.87M 4.37B | Net cash position 2024 * | 120M 129M 116M 10.78B | EV / Sales 2024 * | 4.25 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
10.1
x | Employees | - |
Yield 2023 |
3.65% | Yield 2024 * |
2.72% | Free-Float | 44.36% |
Latest transcript on Cosmo Pharmaceuticals S.p.A
Managers | Title | Age | Since |
---|---|---|---|
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 01/16/01 |
Chairman | 61 | 01/06/01 | |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 69 | 01/97/01 | |
Director/Board Member | 69 | 01/12/01 | |
Chairman | 61 | 01/06/01 |
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |